Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006695	-toxonho	— (—)	578	1166	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AA Selective immunosuppressants

209

28.47

311.26

3.3

1.1

—

Transplanted organ and tissue status

228

93.11

307.65

3.4

1.0

—

L04AD Calcineurin inhibitors

212

63.69

307.65

3.5

1.1

—

ILD medications: immunosuppressive drugs

302

130

22.46

307.65

2.9

1.1

—

Other respiratory diseases principally affecting the interstitium

158

34.34

249.40

3.0

1.9

—

Other interstitial pulmonary diseases

149

40.20

245.29

3.1

1.7

—

ILD, hospital admissions

149

39.18

243.68

3.1

1.7

—

Interstitial lung disease endpoints

149

39.16

243.66

3.1

1.7

—

Interstitial lung disease

149

39.16

243.66

3.1

1.7

—

ILD, hospital admission 2, with pulmonary infections

126

86.88

239.03

3.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

338

158

12.14

238.70

2.5

1.1

—

ILD, hospital admissions 1, main diag only

139

40.80

229.59

3.1

1.7

—

ILD medications

334

160

11.50

225.15

2.5

1.1

—

Oral corticosteroids

331

206

9.76

216.68

2.6

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

149

80.50

212.89

3.1

1.4

—

First line medication for Crohn's disease

306

141

11.88

208.82

2.3

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

105

77.56

196.02

3.1

1.3

—

Inflammatory bowel disease treatment related agents

329

211

8.89

195.53

2.6

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

297

247

8.36

189.76

2.4

1.6

—

Influenza and pneumonia

306

246

8.21

187.49

2.5

1.6

—

276

181

9.60

182.68

2.5

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

276

181

9.60

182.68

2.5

1.5

—

All pneumoniae

294

256

7.96

180.73

2.5

1.6

—

Pneumonia, organism unspecified

266

225

8.59

177.31

2.5

1.6

—

Idiopathic pulmonary fibrosis

100

51.82

174.07

3.6

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

278

238

7.97

169.73

2.9

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

277

270

7.24

159.65

2.5

1.6

—

Primary_lymphoid and hematopoietic malignant neoplasms

130

16.44

154.23

1.5

2.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

130

15.85

151.43

1.5

2.2

—

Fever of other and unknown origin

181

187

9.02

142.15

1.9

2.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

191

242

7.35

127.09

2.0

2.1

—

Abnormal findings on diagnostic imaging of lung

156

171

8.94

124.56

2.1

—

Bacterial pneumonia (organism specified)

143

153

8.56

107.02

2.5

1.6

—

Bacterial infection, other or unspecified

155

183

7.68

105.84

1.8

2.1

—

Implicit viral Sepsis

15.59

101.67

2.5

2.0

—

Viral Sepsis

15.59

101.67

2.5

2.0

—

Early onset COPD, excluding more controls

22.72

96.09

3.3

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

20.84

95.29

1.5

2.2

—

Other bacterial diseases

223

304

5.09

92.21

2.0

2.1

—

Other diseases of pleura

136

160

7.57

91.08

2.9

1.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

222

323

4.94

90.30

2.0

—

COPD-related respiratory insufficiency

18.87

84.84

3.6

1.4

—

ILD medications: azathioprine

19.56

82.48

2.0

1.1

—

Bacterial pneumoniae

106

104

9.06

81.81

2.8

1.5

—

Bacterial pneumonia, not elsewhere classified

102

9.35

80.51

2.9

1.5

—

COPD/asthma related infections

200

181

5.55

77.49

2.1

1.5

—

COPD/asthma/ILD related infections

200

181

5.55

77.49

2.1

1.5

—

Other respiratory disorders and diseases

11.94

76.30

3.4

1.5

—

Other diseases of the respiratory system

11.94

76.30

3.4

1.5

—

Non-follicular lymphoma, hilmo, excluding all cancers

23.82

75.29

1.4

2.2

—

Dialysis, with operation codes

14.75

75.02

2.5

2.0

—

Bacterial Sepsis

120

156

6.87

74.12

2.3

1.8

—

Protozoal diseases

37.13

73.51

1.8

2.0

—

Azathioprine

14.67

71.56

2.0

1.3

—

L04AX Other immunosuppressants

144

275

5.26

71.09

2.2

2.0

—

Implicit bacterial Sepsis

107

135

7.30

70.63

2.4

1.8

—

Second line medication for Crohn's disease

147

288

5.12

70.51

2.2

2.0

—

Dental caries

105

8.35

67.23

2.8

1.8

—

Other diseases of blood and blood-forming organs, wide

9.25

65.64

2.0

1.9

—

Certain infectious and parasitic diseases

172

161

5.36

64.70

2.1

1.6

—

Dentinal caries

8.90

64.41

2.8

1.7

—

Non-follicular lymphoma

16.60

64.24

1.4

1.8

—

Infections, IBD-co-morbidities

15.35

62.89

2.5

1.2

—

Implicit Sepsis

157

259

4.73

62.88

2.5

1.9

—

Viral infections characterized by skin and mucous membrane lesions

114

199

5.75

62.05

2.2

1.9

—

Fungal Sepsis

31.69

61.17

2.3

2.2

—

Nephropathy related operations

11.84

60.98

2.4

2.1

—

Persons encountering health services for specific procedures and health care

210

336

3.88

60.68

2.3

1.9

—

General symptoms and signs

200

238

4.22

58.68

2.1

1.9

—

Pulmonary heart disease, diseases of pulmonary circulation

119

7.26

58.66

2.6

1.9

—

Implicit fungal Sepsis

32.66

58.59

2.3

—

Chronic kidney disease

8.19

58.12

2.2

2.0

—

Certain disorders involving the immune mechanism

8.83

56.93

1.9

—

Oxycodone

142

6.43

56.57

1.8

1.9

—

Other acute lower respiratory infections

123

237

4.97

56.20

3.1

1.7

—

COPD (mode)

12.24

55.68

3.3

1.1

—

Viral pneumonia

17.44

54.93

2.6

1.2

—

202

277

3.86

54.45

2.3

1.6

—

Acute bronchitis

157

6.01

54.40

3.2

1.5

—

Bronchitis

197

353

3.67

53.97

2.6

1.6

—

Mycoses

115

7.00

52.78

2.7

1.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

165

302

3.98

52.31

2.5

1.9

—

All influenza

9.72

51.79

2.4

1.2

—

Renal failure

102

169

5.54

51.73

2.1

2.0

—

Other viral diseases

133

6.40

51.58

2.5

1.9

—

Early onset COPD

7.83

50.95

3.3

1.8

—

Diagnoses used for exclusion with ILD

7.41

50.73

2.2

2.0

—

Asthma

114

100

6.12

50.17

2.7

1.2

—

Cytomegaloviral disease

31.22

50.02

2.8

1.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

8.31

49.67

3.4

1.6

—

ILD-related respiratory insufficiency

73.58

49.55

3.8

1.0

—

Covid-19 confirmed case

111

6.88

49.41

2.7

1.6

—

Other medical care

149

5.85

49.04

1.9

1.7

—

Asthma, excluding more controls

112

6.10

48.98

2.7

1.2

—

Other pulmonary diagnosis

118

100

5.92

48.66

2.2

1.2

—

Cytomegalovirus infection, IBD co-morbidity

28.68

48.64

2.8

1.7

—

Other pulmonary heart/vessel disease

24.76

47.86

3.6

1.7

—

Provisional assignment of new diseases of uncertain etiology

101

204

4.97

46.92

2.5

1.8

—

Codes for special purposes

101

206

4.92

46.40

2.5

1.9

—

Asthma (only as main-diagnosis), excluding more controls

100

6.09

46.24

2.8

1.2

—

Asthma (only as main-diagnosis)

100

6.04

46.23

2.8

1.2

—

Respiratory insufficiency

75.39

46.01

3.6

1.1

—

Inflammatory diseases of the central nervous system

13.10

46.00

1.5

2.1

—

Chronic periodontitis

10.07

45.99

3.4

1.7

—

Secondary right heart disease

24.08

45.93

3.7

1.7

—

Zoster [herpes zoster]

9.70

45.63

2.2

1.7

—

Other/unspecified cytomegaloviral diseases

31.41

45.44

2.7

1.4

—

Asthma-related pneumonia

153

5.57

44.84

3.2

1.7

—

Emphysema

17.03

44.50

3.2

1.5

—

COPD, hospital admission 2, with asthma infections

6.74

44.25

3.3

1.7

—

Asthma, hospital admissions 3, pneumonia

155

5.50

44.22

3.2

1.7

—

Asthma-related pneumonia or sepsis

155

5.50

44.22

3.2

1.7

—

Excluding asthma or asthma-COPD overlap

112

100

5.62

44.16

2.2

1.2

—

Diffuse large B-cell lymphoma

29.54

43.29

1.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

97.83

43.09

1.9

1.4

—

Septicaemia

138

5.66

42.93

2.0

—

COPD differential diagnosis

110

101

5.46

42.30

2.2

1.3

—

ILD differential diagnosis

110

101

5.46

42.30

2.2

1.3

—

Explicit Sepsis

157

5.27

42.14

1.9

1.7

—

Immunodeficiencies

20.34

41.64

1.6

—

Myeloid leukaemia

28.85

41.36

1.4

1.7

—

Abnormalities of breathing

157

257

3.64

41.17

2.3

1.8

—

Agranulocytosis

10.56

41.08

2.0

2.1

—

Acute upper respiratory infections of multiple and unspecified sites

138

279

3.71

40.42

2.5

1.8

—

Acute renal failure

8.43

40.28

2.3

2.1

—

Any gastric operation

111

112

4.98

39.14

2.2

1.3

—

GASTRO-related operations

111

112

4.98

39.14

2.2

1.3

—

Diseases of oesophagus, stomach and duodenum

183

355

3.14

38.93

2.7

1.7

—

Acute upper respiratory infections

174

340

3.21

38.81

2.3

1.8

—

Anaemias

8.28

38.71

2.0

1.8

—

Other septicaemia

123

5.68

38.09

2.0

2.1

—

COPD

165

4.66

37.66

3.0

1.7

—

Chronic periapical parodontitis

7.27

37.64

2.9

1.8

—

Asthma, unspecified (mode), excluding more controls

6.43

37.09

2.7

1.2

—

Direct fill therapy

7.79

36.95

3.0

2.0

—

Lymphoid leukaemia

22.78

36.76

1.3

2.2

—

Asthma, unspecified (mode)

6.33

36.76

2.7

1.3

—

Acute sinusitis

101

231

4.09

36.14

2.5

1.7

—

Failure and rejection of transplanted organs and tissues

72.71

35.59

3.3

2.2

—

Pneumocystosis

50.58

35.26

1.8

1.4

—

Dyspnoea

151

366

3.17

35.11

2.4

1.9

—

Encephalitis

22.18

34.91

1.5

1.6

—

Any reimbursement code in KELA

5.84

34.79

2.3

1.0

—

Tramadol

132

239

3.56

34.64

2.2

2.0

—

Renal tubulo-interstitial diseases

148

360

3.16

34.31

2.2

1.9

—

Care involving use of rehabilitation procedures

111

289

3.65

34.21

2.3

1.9

—

Malignant neoplasm

151

275

3.26

33.95

1.7

2.5

—

Immunodeficiency with predominantly antibody defects

24.59

33.48

1.3

1.7

—

Other encephalitis

24.56

33.48

1.5

1.7

—

Deposits [accretions] on teeth

14.39

33.47

3.0

1.3

—

Asthma (mode)

101

4.95

33.41

2.4

1.3

—

COPD, hospital admissions 1, only main diagnosis

109

5.41

33.38

3.4

1.6

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

147

265

3.28

33.36

1.9

2.5

—

Malignant neoplasm, wide definition for exclusion

147

266

3.27

33.17

1.9

2.5

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

147

266

3.27

33.17

1.9

2.5

—

Pain, not elsewhere classified

6.45

33.15

3.4

1.9

—

Other metabolic disorders

8.78

32.76

2.9

1.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

172

325

2.95

32.33

1.8

2.2

—

Heart failure, not strict

135

285

3.27

32.09

2.5

2.0

—

Autoimmune diseases excluding thyroid diseases

174

333

2.90

31.77

1.8

2.2

—

Reimbursement for rheumatic diseases

104

293

3.55

31.15

1.8

2.0

—

Other chronic obstructive pulmonary disease

160

4.32

30.86

3.1

1.6

—

Pulmonary embolism

110

5.38

30.11

2.1

2.0

—

Kidney transplant status

12.79

29.79

2.2

2.8

—

Enlarged lymph nodes

8.16

29.45

1.2

1.8

—

Lymphoid leukaemia

13.67

28.83

1.3

2.1

—

Neoplasms

121

187

3.47

28.81

2.2

2.1

—

Pulmonary heart disease

115

5.15

28.68

2.1

2.0

—

Drug-induced cataract

20.52

28.50

2.6

1.7

—

L01XE Protein kinase inhibitors

11.26

28.48

2.2

1.8

—

Abnormal findings on diagnostic imaging of central nervous system

20.25

28.45

1.2

1.4

—

COPD, hospital admissions

175

4.02

28.34

3.1

1.9

—

COPD, early/later onset

176

3.99

28.02

3.1

1.9

—

Asthma, hospital admission 2, infections

102

302

3.33

27.63

2.9

1.8

—

Asthma-related infections

102

302

3.33

27.63

2.9

1.8

—

Autoimmune diseases related-to ILD

116

327

3.12

27.56

1.7

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

16.67

27.20

1.7

—

Aplastic and other anaemias

187

3.96

27.05

2.1

1.9

—

Chronic lower respiratory diseases

183

383

2.59

27.00

2.7

1.7

—

Lung diseases due to external agents

8.04

26.85

2.6

1.9

—

Non-Hodgkin lymphoma, all

17.17

26.38

1.2

1.5

—

Other and unspecified anaemias

171

4.08

26.15

2.2

1.9

—

Unspecified acute lower respiratory infection

7.21

25.82

3.2

1.2

—

Other anaemias

173

4.03

25.64

2.2

1.9

—

Viral warts

9.18

25.61

2.3

1.8

—

Diseases of pulp and periapical tissues

169

4.09

25.40

2.8

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

7.95

25.11

1.2

2.1

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

49.19

24.33

1.6

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

49.19

24.33

1.6

1.2

—

Myeloid leukaemia

57.66

24.14

1.4

2.0

—

Pneumothorax

11.46

24.02

3.5

2.4

—

Continuous positive airway pressure

5.65

23.98

2.8

1.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

13.84

23.65

1.8

2.3

—

All influenza (not pneumonia)

8.60

23.62

2.5

1.2

—

Any event in cancer register

138

298

2.75

23.57

1.7

2.4

—

Drug-induced neutropenia

9.42

23.54

2.0

1.7

—

Examination and observation for other reasons

168

3.44

23.51

2.6

1.6

—

Coagulation defects, purpura and other haemorrhagic conditions

5.37

23.48

1.7

1.8

—

Disorders of lens

116

245

2.99

23.38

2.3

2.2

—

COPD related to multimorbidity

139

4.07

23.25

3.3

1.8

—

221

3.51

23.05

2.9

1.7

—

Diseases of the respiratory system

4.32

22.96

2.0

1.3

—

Herpesviral [herpes simplex] infections

7.66

22.92

1.9

1.7

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

141

4.06

22.80

1.3

2.5

—

Osteopathies and chondropathies

267

3.20

22.79

2.0

1.9

—

Intestinal infectious diseases

139

421

2.57

22.58

2.1

2.0

—

Metabolic disorders

141

333

2.63

22.56

2.5

1.9

—

Cough

163

3.89

22.48

2.0

1.7

—

DVT of lower extremities and pulmonary embolism

203

3.59

22.39

2.3

1.9

—

Other cataract

157

3.71

22.38

2.1

—

Care involving dialysis

9.70

22.34

1.6

1.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

109

349

2.84

22.24

2.0

1.9

—

Other reaction to severe stress, and adjustment disorders

183

3.73

22.02

2.5

1.8

—

Rare circulating lymphoid malignancy

16.09

21.98

1.5

1.8

—

Seborrhoeic keratosis

5.47

21.90

2.5

2.0

—

6.20

21.88

3.5

1.8

—

Osteoporosis

5.00

21.81

2.1

1.7

—

Other disorders of skin and subcutaneous tissue

104

335

2.85

21.37

2.3

1.9

—

Other necrotizing vasculopathies (FG)

11.68

21.36

1.6

1.8

—

Other chronic obstructive pulmonary disease, including avohilmo

227

3.19

21.22

3.1

1.9

—

Secondary uncertain malignant neoplasm

7.25

21.18

1.3

1.8

—

Venous thromboembolism

263

3.14

21.03

2.1

2.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

8.50

21.01

1.2

1.9

—

Viral infections of the central nervous system

10.53

20.90

1.5

2.5

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

11.74

20.46

1.5

2.3

—

Dermatitis

334

2.85

19.95

2.2

1.9

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

36.36

19.87

1.5

1.7

—

Other and unspecified dermatitis

266

3.09

19.87

2.0

1.8

—

Melanocytic naevi

100

4.61

19.78

2.8

2.1

—

Other disorders of teeth and supporting structures

5.14

19.52

3.2

1.7

—

Bronchiectasis

10.07

19.38

2.0

1.4

—

Viral pneumonia (unknown virus, not influenza)

10.58

19.12

2.8

2.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.55

19.09

3.0

2.2

—

Pleural effusion

6.93

19.07

2.8

1.5

—

Opioids

133

275

2.54

18.97

2.2

1.9

—

Other necrotizing vasculopathies

9.64

18.78

1.6

1.7

—

Pain in throat and chest

110

247

2.72

18.77

2.3

1.8

—

Gastro-oesophageal reflux disease

312

2.76

18.69

2.4

1.8

—

Candidiasis

6.07

18.55

2.8

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

16.15

18.52

1.7

1.5

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

16.15

18.52

1.8

1.5

—

Missing teeth due to accident, extraction or parodontitis

7.46

18.22

3.6

1.6

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

33.34

17.98

1.7

3.0

—

Headache

208

3.10

17.98

1.6

1.8

—

Autoimmune diseases

152

334

2.33

17.94

1.9

2.2

—

Systemic connective tissue disorders

157

3.64

17.92

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

130

260

2.51

17.84

2.3

1.8

—

Other viral diseases, not elsewhere classified

4.71

17.64

2.9

2.0

—

Other heart diseases, wide

130

334

2.42

17.64

2.3

1.9

—

Other heart diseases

153

3.24

17.59

2.4

1.8

—

Other and unspecified polyneuropathies, also in other diseases

5.02

17.57

2.2

1.8

—

Polyneuropathies and other disorders of the peripheral nervous system

4.61

17.23

2.1

1.9

—

Allergic asthma (mode)

6.02

17.19

2.5

1.1

—

Allergic asthma (mode), excluding more controls

6.02

17.18

2.5

1.1

—

Chorioretinal inflammation

26.08

16.95

1.4

1.9

—

Sarcoidosis

5.35

16.81

2.1

2.0

—

Extracorporeal dialysis

8.82

16.79

1.7

2.1

—

Thrombocytopenia, unspecified

8.81

16.78

1.5

1.9

—

Other disorders of fluid, electrolyte and acid-base balance

122

3.88

16.74

1.6

—

Asthma/COPD (KELA code 203)

127

382

2.35

16.73

2.8

1.7

—

Dermatitis and eczema

145

429

2.22

16.51

2.2

1.9

—

Complications of medical and surgical care

101

385

2.49

16.25

2.0

—

Chronic lymphocytic leukaemia

12.50

16.06

1.0

1.5

—

Persons encountering health services in other circumstances, wide

158

379

2.17

15.97

2.1

1.9

—

Malaise and fatigue

138

3.45

15.79

2.0

1.8

—

General examination and investigation of persons without complaint and reported diagnosis

170

2.82

15.71

2.6

1.6

—

Osteonecrosis

9.12

15.55

1.9

2.0

—

Benign neoplasms

207

2.65

15.49

2.4

2.2

—

Hypo-osmolality and hyponatraemia

5.58

15.45

1.3

1.8

—

Dermatophytosis

5.74

15.37

2.1

1.7

—

Cardiovascular diseases (excluding rheumatic etc)

187

2.75

15.29

2.2

1.8

—

Purpura and other haemorrhagic conditions

5.29

15.11

1.4

1.9

—

Convulsions, not elsewhere classified

4.62

15.08

2.1

—

SLE (Finngen)

14.14

15.06

1.9

1.5

—

Disorders of eyelid, lacrimal system and orbit

110

368

2.35

14.94

2.0

2.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.61

14.91

2.1

1.7

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

32.17

14.83

1.5

1.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

142

377

2.15

14.53

2.1

2.0

—

Chronic periodontitis, complicated

5.81

14.45

3.8

2.1

—

Melanocytic naevi

128

3.60

14.32

2.8

1.7

—

Cystic fibrosis with pulmonary manifestations

+∞

14.27

4.5

0.0

—

Senile cataract

213

2.59

14.04

2.5

2.1

—

Acute myeloid leukaemia and myelodysplastic syndromes

30.80

13.94

1.6

1.3

—

Diseases of the skin and subcutaneous tissue

127

284

2.24

13.90

2.6

1.7

—

Asthma (diagnoses ohter than nonallergic)

113

435

2.22

13.84

2.7

1.9

—

Viral pneumonia (known virus, not influenza)

24.27

13.83

2.9

1.4

—

Focal epilepsy, strict definition

4.28

13.79

1.8

1.9

—

Medical observation and evaluation for suspected diseases and conditions

170

2.65

13.67

2.3

1.6

—

Cardiovascular diseases

164

2.73

13.65

2.1

1.7

—

Heart failure and antihypertensive medication

3.87

13.62

2.5

1.2

—

Enterocolitis due to Clostridium difficile

6.80

13.57

2.2

1.7

—

Systemic lupus erythematosus

11.78

13.54

1.9

1.3

—

Diaphragmatic hernia

174

3.11

13.37

2.0

1.8

—

Benign neoplasm of other and ill-defined parts of digestive system

5.57

13.34

2.5

2.3

—

Complications of surgical and medical care, not elsewhere classified

124

418

2.13

13.18

2.1

2.0

—

Iridocyclitis

103

3.80

13.11

1.2

2.0

—

Cystic fibrosis with intestinal manifestations

+∞

13.03

4.8

0.0

—

Focal epilepsy

3.90

12.93

1.7

1.9

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

22.69

12.89

1.6

2.8

—

Chronic iridocyclitis

8.16

12.76

1.2

2.7

—

Haemorrhage from respiratory passages

127

3.37

12.73

2.8

1.8

—

Gastrointestinal diseases

129

2.84

12.70

2.3

1.4

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

7.52

12.68

2.1

1.8

—

Non-allergic asthma (mode)

6.32

12.65

3.2

1.1

—

Non-allergic asthma (mode), excluding more controls

6.31

12.65

3.2

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

32.49

12.59

1.0

3.0

—

Chronic lymphocytic leukaemia, helper endpoint

32.49

12.59

1.0

3.0

—

Used for control exclusion in common control thyroid runs

131

314

2.12

12.57

1.9

2.2

—

Presence of other functional implants

136

3.02

12.55

1.6

1.1

—

Glomerular disorders in diseases classified elsewhere

5.23

12.47

1.6

2.2

—

Epilepsy

145

3.24

12.46

1.7

—

Myeloproliferative diseases

6.49

12.36

1.3

1.8

—

Codeine

110

272

2.22

12.18

2.4

1.9

—

Disorders of sclera, cornea, iris and ciliary body

303

2.48

12.17

1.4

2.1

—

Asthma and opportunity respiratory infection

8.90

12.01

2.9

2.0

—

Acute bronchiolitis

10.54

11.98

2.2

1.8

—

Factors influencing health status and contact with health services

4.26

11.92

2.4

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.99

11.88

1.8

2.0

—

Cardiac arrhythmias

209

2.50

11.88

2.3

1.8

—

Undetermined asthma

7.40

11.82

2.1

1.2

—

Undetermined asthma, excluding more controls

7.40

11.82

2.1

1.2

—

Non-invasive ventilation

3.77

11.80

2.7

1.4

—

Oedema, not elsewhere classified

101

3.65

11.79

3.3

1.9

—

12.16

11.76

2.5

1.6

—

Other bacterial intestinal infections

4.24

11.71

2.1

1.9

—

Bacterial intestinal infections, IBD co-morbidities

4.24

11.70

2.1

1.9

—

Multiple myeloma and malignant plasma cell neoplasms

7.68

11.43

1.8

1.6

—

Other diseases of hard tissues of teeth

244

2.42

11.42

2.5

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

330

2.36

11.37

2.2

2.1

—

Secondary hypertension

8.28

11.35

1.4

2.3

—

Respiratory disorders in diseases classified elsewhere

25.73

11.20

2.3

1.3

—

Glomerular diseases

3.87

11.07

1.5

2.0

—

Carcinoma in situ of skin

10.95

11.06

4.0

2.3

—

Cerebrovascular diseases (FINNGEN)

107

3.15

10.94

1.8

—

Disorders of lacrimal system

191

2.78

10.85

2.0

1.8

—

Benign neoplasm: Colon

146

2.84

10.78

2.4

2.6

—

Asthma, hospital admissions , main diagnosis only

102

440

2.08

10.75

2.8

1.9

—

Nausea and vomiting

111

3.37

10.75

1.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

170

2.41

10.53

2.5

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

144

2.69

10.49

2.0

1.8

—

Other disorders involving the immune mechanism, not elsewhere classified

10.10

10.45

2.1

2.0

—

SLE, strict definition

10.08

10.45

2.0

1.6

—

SLE, ICD10

10.08

10.45

2.0

1.6

—

Benign neoplasm of colon, rectum, anus and anal canal

166

2.63

10.38

2.4

2.6

—

In situ neoplasms

105

3.37

10.37

2.9

1.9

—

Statin medication

214

2.28

10.35

3.1

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

5.14

10.30

1.5

1.6

—

Retinal vascular occlusion

5.61

10.21

1.7

1.8

—

Retinal vascular disorders

5.61

10.21

1.7

1.8

—

Malignant neoplasm of eye, brain and central nervous system

7.84

10.15

1.7

2.9

—

Chronic sinusitis

245

2.49

10.09

2.5

1.8

—

Benign neoplasms

122

347

1.96

10.00

2.3

1.9

—

Status epilepticus

16.83

9.88

1.2

1.9

—

Carcinoma in situ of skin of other and unspecified parts of face

16.75

9.87

3.1

1.6

—

Persons encountering health services for specific procedures, not carried out

6.43

9.81

3.2

1.8

—

Other disorders of lacrimal gland

152

2.90

9.77

2.0

1.9

—

Carcinoma in situ of skin of other and unspecified parts of face

6.85

9.73

3.1

1.4

—

Preparatory care for dialysis

7.43

9.71

1.1

2.4

—

Disorders of calcium metabolism

7.41

9.70

2.0

1.4

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.09

9.55

2.2

2.1

—

Systemic lupus erythematosus, unspecified

10.09

9.55

2.0

1.6

—

Haemolytic anaemias

10.08

9.55

2.1

1.4

—

Hypertensive diseases (excluding secondary)

151

2.50

9.54

2.6

1.8

—

Other skin changes

4.01

9.49

2.3

2.0

—

Other and unspecified immunodeficiencies with predominantly antibody defects

18.02

9.46

1.5

1.9

—

Other benign neoplasms of skin

121

3.08

9.36

2.1

2.2

—

Anxiety disorders, excluding more controls

105

350

1.99

9.34

2.4

2.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.32

9.33

2.1

—

Chronic periodontitis, including avohilmo

107

405

1.96

9.29

2.5

2.0

—

Tuberculosis

7.03

9.28

2.0

1.6

—

Other disorders of gingiva or/and edentulous alveolar ridge

7.69

9.28

2.5

1.4

—

Chronic gastritis

109

3.22

9.27

3.3

1.6

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

156

2.54

9.19

1.9

2.6

—

Parodontitis

107

405

1.95

9.19

2.5

2.0

—

Parodontitis or operation codes

107

405

1.95

9.17

2.5

2.0

—

Squamous cell neoplasms and carcinomas of the skin

5.31

9.15

2.1

1.7

—

Other pleural conditions

5.95

9.12

2.8

1.6

—

Symptoms and signs involving the skin and subcutaneous tissue

396

2.09

9.11

2.3

1.9

—

Visual disturbances and blindness

264

2.35

9.09

1.5

1.9

—

Ulcer of lower limb, not elsewhere classified

4.77

9.05

1.2

2.1

—

Other gastritis (incl. Duodenitis)

3.50

9.04

2.6

1.6

—

Invasive ventilation

6.28

8.99

1.3

2.1

—

Melanocytic naevi, other sites/unspecified

6.28

8.99

2.8

1.9

—

Erysipelas

218

2.43

8.98

1.8

2.3

—

Gastroduodenal ulcer

3.40

8.98

2.0

1.8

—

Sulfasalazine

3.64

8.97

1.3

1.1

—

Gingivitis and periodontal diseases

250

2.05

8.92

2.0

1.7

—

Streptococcal septicaemia

6.69

8.89

1.6

2.5

—

Polyarthropathies

304

2.04

8.88

1.6

2.3

—

Malignant neoplasm of brain

8.07

8.87

1.8

3.0

—

Anterior Iridocyclitis

3.31

8.86

1.3

1.9

—

Non-rheumatic valve diseases

172

2.46

8.80

1.7

2.0

—

Presence of cardiac and vascular implants and grafts

110

2.89

8.71

2.0

1.1

—

Unspecified kidney failure

6.02

8.65

2.3

1.9

—

Bleeding

363

1.97

8.63

2.4

2.0

—

Valvular heart disease excluding rheumatic fever

174

2.44

8.62

1.7

2.0

—

Methotrexate

5.01

8.60

1.2

—

Viral encephalitis, not elsewhere classified/unspecified

16.52

8.57

1.5

1.4

—

Neurotic, stress-related and somatoform disorders

108

405

1.90

8.55

2.4

2.0

—

Tuberculosis, IBD comorbidity

6.39

8.53

2.0

—

Pneumonitis due to solids and liquids

6.39

8.52

2.3

1.8

—

Benign neoplasm: Stomach

6.38

8.52

2.2

—

Heart failure,strict

186

2.37

8.50

2.3

1.9

—

Infection due to other mycobacteria

20.39

8.50

2.7

1.2

—

Diseases of oral cavity, salivary glands and jaws

250

2.01

8.47

2.2

1.7

—

Anxiety disorders

108

406

1.89

8.41

2.4

2.0

—

Obesity related asthma

171

2.64

8.41

2.8

1.8

—

Procreative management

142

2.68

8.35

2.5

1.9

—

Dysphagia

101

3.17

8.33

1.6

1.8

—

Benign neoplasm of other and ill-defined parts of digestive system

3.74

8.32

2.5

1.7

—

Nutritional anaemias

219

2.40

8.29

2.0

1.9

—

Other diseases of intestines

122

388

1.83

8.27

2.2

2.0

—

Atrial fibrillation and flutter

107

2.75

8.21

2.6

1.9

—

Asthma and allergy, excluding more controls

5.71

8.18

2.3

1.1

—

Asthma and allergy

5.71

8.18

2.3

1.1

—

Explicit bacterial Sepsis

5.01

8.13

1.6

2.0

—

Bacterial, viral and other infectious agents

4.76

8.11

2.3

—

Glaucoma secondary to other eye disorders

9.14

8.09

1.0

1.8

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

3.47

8.07

1.0

2.3

—

Other diseases of lip and oral mucosa

4.01

8.05

2.1

1.7

—

Other disorders of pigmentation

7.90

7.99

3.6

1.3

—

Neurological diseases, wide definition

3.32

7.91

2.3

1.2

—

Antihypertensive medication - note that there are other indications

176

2.21

7.90

2.5

1.2

—

Elevated blood glucose level

4.88

7.88

2.6

2.4

—

Disorders of optic nerve and visual pathways

4.63

7.87

2.1

1.7

—

Tuberculosis, wide

5.85

7.85

2.0

1.9

—

Diseases of salivary glands

3.58

7.83

2.5

1.6

—

Visual disturbances

245

2.29

7.78

1.5

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

137

2.51

7.77

1.9

2.5

—

Abnormalities of heart beat

137

2.75

7.73

2.3

1.6

—

Disorders of mineral metabolism

5.38

7.72

2.0

1.6

—

Functional dyspepsia

106

3.02

7.71

3.1

1.5

—

Diseases of the eye and adnexa

239

1.97

7.68

2.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

334

2.04

7.66

2.5

2.0

—

Other diseases of pericardium

7.38

7.56

2.3

1.9

—

Benign neoplasm: Skin of other and unspecified parts of face

5.61

7.54

2.1

—

Iron deficiency anaemia

185

2.47

7.53

2.1

1.9

—

Gastric ulcer

3.90

7.41

2.4

1.5

—

Benign neoplasm: Ascending colon

4.86

7.40

2.2

2.1

—

Gingival hyperplasia

13.45

7.39

2.6

1.7

—

Other diseases of upper respiratory tract

126

374

1.76

7.38

2.0

1.9

—

Dermatitis due to substances taken internally

5.94

7.38

2.8

2.2

—

Maternal care for known or suspected fetal abnormality and damage

3.41

7.37

1.5

1.6

—

Meningitis

6.35

7.24

1.2

2.8

—

Abdominal and pelvic pain

115

323

1.79

7.11

2.2

2.1

—

Neurological diseases

248

1.91

7.07

2.2

2.0

—

Other infectious diseases

5.20

6.97

1.6

2.3

—

Insulin medication

320

1.98

6.95

2.5

2.0

—

Hernia of abdominal wall, postoperative

4.85

6.92

1.4

1.2

—

Wegener granulomatosis

13.99

6.91

2.0

1.5

—

Disorders of tooth development and eruption

6.72

6.91

2.4

1.3

—

Paroxysmal tachycardia

3.07

6.91

1.9

—

Retinal detachments and breaks

177

2.43

6.89

1.7

2.0

—

Acute and subacute iridocyclitis

3.05

6.87

1.3

1.9

—

Parodontitis and operation codes

412

1.81

6.82

2.5

2.0

—

Symptoms and signs involving the digestive system and abdomen

114

323

1.77

6.80

2.1

—

Other disorders of conjunctiva

3.78

6.79

1.6

2.1

—

Osteoporosis with pathological fracture (FG)

6.49

6.78

2.4

1.4

—

Atypical mycobacterium lung infection

17.04

6.77

3.0

1.3

—

Diseases of arteries, arterioles and capillaries

290

1.96

6.75

1.9

2.1

—

Speech therapy

126

2.70

6.74

2.7

1.9

—

Other coagulation defects

5.02

6.70

2.2

1.7

—

Other and unspecified disorders of white blood cells

7.18

6.70

2.7

1.9

—

Ischaemic heart disease, wide definition

298

1.87

6.68

2.4

2.1

—

Parasetamol

232

1.92

6.66

2.5

1.7

—

Pain in limb

364

1.83

6.65

2.3

2.0

—

Use of antiglaucoma preparations and miotics

5.73

6.58

1.7

1.6

—

Lung cancer and mesothelioma

4.76

6.45

2.3

1.1

—

Myeloproliferative diseases (CML excluded)

4.85

6.45

1.4

1.8

—

Respiratory tuberculosis

6.14

6.43

2.3

1.7

—

Respiratory tuberculosis, confirmed and not-confirmed

6.14

6.43

2.3

1.7

—

Respiratory conditions due to other external agents

14.47

6.41

1.5

1.9

—

Syncope and collapse

134

2.51

6.39

2.0

1.9

—

Covid-19 suspected case

2.97

6.36

2.3

1.6

—

Neovascular glaucoma

6.70

6.31

1.0

1.7

—

Vocal cord dysfunction

3.76

6.29

1.6

1.7

—

L01XX Other antineoplastic agents

5.48

6.29

1.0

2.0

—

Other inflammation of eyelid

3.84

6.25

1.5

2.0

—

Other diseases of oesophagus

5.01

6.22

2.5

1.5

—

Infections of the skin and subcutaneous tissue

344

1.94

6.17

1.9

2.1

—

Codeine or tramadol medication

126

422

1.65

6.13

2.4

1.9

—

Other epidermal thickening

5.82

6.11

2.6

1.9

—

Acute generalized exanthematous pustulosis

5.82

6.11

2.8

1.7

—

Other specified/unspecified systemic involvement of connective tissue

5.81

6.11

2.7

1.4

—

Asthma, including avohilmo

127

449

1.64

6.10

2.7

1.8

—

Heart failure, strict

220

2.03

6.09

2.3

2.0

—

Other and unspecified iron deficiency

133

2.56

6.09

2.3

1.8

—

Disorders of choroid and retina

357

1.80

6.05

1.5

2.2

—

Cardiodefibrillation

188

2.29

6.05

2.4

2.1

—

Nonsuppurative otitis media

2.71

6.01

2.0

1.8

—

Other disorders of optic [2nd] nerve and visual pathways

5.24

6.01

2.6

1.9

—

Mixed connective tissue disease

5.24

6.01

2.6

1.4

—

Other peripheral vascular diseases

4.83

5.97

1.9

1.7

—

Symptoms and signs concerning food and fluid intake

4.82

5.96

2.2

2.0

—

Other and unspecified coagulation defects

6.28

5.96

2.2

1.5

—

Other soft tissue disorders, not elsewhere classified

105

379

1.71

5.94

2.3

2.0

—

Biological medication for rheuma

2.98

5.94

1.4

1.9

—

Personal history of other diseases and conditions

4.51

5.94

3.8

1.0

—

Ischemic heart diseases

306

1.80

5.93

2.4

2.0

—

Mature T/NK-cell lymphomas, hilmo

15.26

5.92

1.4

1.3

—

Endocrine, nutritional and metabolic diseases

256

1.81

5.92

2.4

1.8

—

Diseases of spleen

15.19

5.92

1.1

1.7

—

Other meningitis

15.19

5.91

1.1

1.3

—

Need for immunization against other single viral diseases

15.16

5.91

2.3

1.3

—

Follicular lymphoma

15.07

5.90

1.1

3.3

—

Insulin, fast-acting

178

2.30

5.88

2.5

1.9

—

Seropositive rheumatoid arthritis, strict definition

3.40

5.85

1.2

2.1

—

Benign neoplasm: Colon

264

2.04

5.84

2.4

2.0

—

Melanocytic naevi, other sites/unspecified

4.18

5.82

2.8

2.2

—

Hypersensitivity pneumonitis due to organic dust

11.28

5.81

4.4

1.7

—

Other disorders of white blood cells

5.52

5.81

2.6

2.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

305

1.96

5.79

2.2

2.0

—

Abnormal results of function studies

4.39

5.76

3.2

2.3

—

Diplopia

3.61

5.75

1.8

1.9

—

Other diseases of blood and blood-forming organs

5.02

5.74

1.8

2.6

—

Other and unspecified vascular occlusions

4.66

5.73

1.8

1.9

—

Other symptoms and signs involving the digestive system and abdomen

3.24

5.71

2.1

1.7

—

Generalized skin eruption due to drugs and medicaments

5.92

5.63

3.0

1.8

—

Budesonide

4.06

5.62

2.2

1.2

—

All-cause Heart Failure

218

1.98

5.58

2.2

2.0

—

Melanocytic naevi of lower limb, including hip

12.92

5.58

3.2

1.7

—

Other neurological diseases

342

1.81

5.58

1.5

2.1

—

Other disorders of eyelid

182

2.23

5.58

2.0

1.8

—

In situ neoplasms

158

2.34

5.54

2.9

1.6

—

Gout, FINNGEN

116

2.59

5.53

2.2

—

Later onset COPD, excluding more controls

4.83

5.51

1.8

1.1

—

Speech disturbances, not elsewhere classified

4.50

5.51

1.1

1.7

—

Disorders of other endocrine glands

219

2.11

5.49

1.7

1.8

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.47

5.44

2.3

2.0

—

Vitreous haemorrhage

3.96

5.43

1.5

2.2

—

Melanocytic naevi of trunk

3.96

5.43

3.2

1.6

—

Intracranial and intraspinal abscess and granuloma

16.28

5.43

2.3

1.4

—

Nocardiosis

+∞

5.33

2.4

0.0

—

DVT of lower extremities

2.92

5.29

2.3

2.0

—

Carcinoma in situ of skin

4.63

5.26

4.0

1.8

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

134

2.22

5.25

2.2

2.6

—

Other leukaemias of specified cell type

+∞

5.25

1.6

0.0

—

Other leukaemias of specified cell type

+∞

5.25

1.6

0.0

—

Fentanyl

5.01

5.25

1.7

2.1

—

Use of hypnotics and sedatives

115

412

1.61

5.21

2.2

2.0

—

Actinic keratosis

142

2.34

5.20

2.7

1.5

—

Benign neoplasm: Stomach

4.01

5.16

2.2

1.6

—

Insulin, fast-acting or short human

189

2.17

5.15

2.5

1.9

—

159

2.25

5.15

2.6

1.6

—

Rheumatoid arthritis, including avohilmo

190

2.16

5.10

1.2

2.0

—

Visual field defects

4.21

5.09

1.4

2.2

—

Demyelinating diseases of the central nervous system

3.76

5.08

1.8

2.0

—

Cellulitis

2.66

5.06

2.1

1.7

—

Hernia

402

1.65

5.06

1.9

2.0

—

Congenital malformations of the circulatory system

2.93

5.06

3.0

1.9

—

Benign neoplasm of colon, rectum, anus and anal canal

307

1.85

5.05

2.4

2.0

—

Acquired haemolytic anaemia

10.09

5.03

1.6

1.3

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

10.05

5.02

1.6

2.6

—

Non-ischemic cardiomyopathy

103

2.47

5.02

2.1

1.6

—

Symptoms and signs involving the urinary system

363

1.73

5.00

2.2

2.0

—

Abnormal findings on examination of blood, without diagnosis

248

1.96

4.98

2.4

2.2

—

Fracture of rib(s), sternum and thoracic spine

129

2.41

4.95

2.2

1.9

—

Deforming dorsopathies

149

2.29

4.84

2.2

1.9

—

AV-block

3.36

4.81

1.8

1.6

—

Hypokalaemia

3.79

4.81

1.3

1.5

—

Disorders of oesophagus in diseases classified elsewhere

11.54

4.79

3.4

1.3

—

Other and unspecified diseases of blood and blood-forming organs

11.52

4.79

1.0

2.1

—

Sequelae of other external causes

5.02

4.78

1.7

2.0

—

Ascites

5.01

4.77

1.3

1.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

128

2.15

4.76

2.1

1.5

—

Injuries to the thorax

244

1.97

4.70

2.3

2.1

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

136

2.13

4.69

2.2

2.5

—

Finngen Rheumatological endpoints

105

373

1.61

4.69

1.9

2.1

—

Skin changes due to chronic exposure to nonionizing radiation

149

2.22

4.65

2.7

1.6

—

Benign neoplasm: Skin of other and unspecified parts of face

3.69

4.64

2.1

1.7

—

Other diseases of intestine

3.21

4.61

1.8

—

Misadventures to patients during surgical and medical care

3.21

4.61

1.1

2.0

—

Benign neoplasm: Ascending colon

3.34

4.60

2.3

1.7

—

Malignant immunoproliferative diseases

14.27

4.59

1.6

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

14.25

4.59

1.0

1.4

—

Coronary atherosclerosis

260

1.76

4.58

2.5

2.1

—

Keratitis

166

2.17

4.57

1.6

2.0

—

Opening and dilatation of root channel of tooth

4.41

4.56

3.5

2.6

—

Benign neoplasm: Transverse colon

4.41

4.56

3.3

2.2

—

Cerebrovascular diseases

320

1.70

4.46

1.8

2.1

—

Other benign neoplasms of skin

181

2.10

4.45

2.1

1.8

—

STROKE

243

1.80

4.44

1.8

2.1

—

Other CVD (FINNGEN)

3.94

4.39

3.4

2.1

—

Diseases of the digestive system

229

1.96

4.39

1.8

1.9

—

Disorders resulting from impaired renal tubular function

7.55

4.36

2.2

1.8

—

Paralytic strabismus

4.24

4.35

1.5

1.9

—

Melanocytic naevi of other and unspecified parts of face

7.52

4.35

1.1

2.3

—

Congenital malformations of cardiac septa

4.27

4.34

2.2

—

Dentofacial anomalies [including malocclusion]

111

2.41

4.34

2.4

1.5

—

Pacemaker

109

2.41

4.33

2.1

1.8

—

Adjustment and management of implanted device

3.20

4.33

2.3

1.8

—

Persons with potential health hazards related to communicable diseases

195

2.04

4.32

2.2

1.9

—

Presence of other devices

3.20

4.32

1.8

1.1

—

Acute tubulo-interstitial nephritis

266

1.83

4.32

2.0

1.9

—

Disorders of muscles

3.34

4.32

1.9

2.0

—

Hyperlipidaemia, other/unspecified

173

2.08

4.31

2.1

1.8

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

119

2.36

4.31

1.1

2.0

—

Cutaneous abscess, furuncle and carbuncle

119

2.36

4.31

1.4

1.8

—

Cerebral cysts

4.56

4.30

2.0

2.5

—

Other symptoms and signs involving the circulatory and respiratory systems

4.56

4.30

2.8

1.5

—

Drug-induced osteoporosis

11.84

4.29

2.9

1.5

—

Human immunodeficiency virus [HIV] disease

8.97

4.29

1.1

3.9

—

Dental operations

178

1.82

4.28

1.9

1.8

—

Persons encountering health services for examination and investigation

170

1.83

4.28

2.4

1.6

—

Pneumonia due to Streptococcus pneumoniae

11.71

4.27

1.4

1.3

—

Other disorders of urethra and urinary system

284

1.74

4.25

1.9

—

Other/unspecified seropositive rheumatoid arthritis

120

2.34

4.23

1.1

2.0

—

Seropositive rheumatoid arthritis, wide

120

2.34

4.23

1.1

2.0

—

Benign neoplasm: Sigmoid colon

3.04

4.23

1.9

2.3

—

Unspecified privation

3.27

4.18

2.3

2.1

—

Cardiomyopathy

2.91

4.16

1.3

1.8

—

Etanercept

4.09

4.16

1.5

2.3

—

Seropositive rheumatoid arthritis

121

2.31

4.14

1.1

1.9

—

Chronic pancreatitis

2.99

4.12

3.8

1.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.99

4.11

1.6

1.7

—

Other specified/unspecified bacterial intestinal infections

4.36

4.09

1.7

1.9

—

Acute gastritis

4.36

4.08

2.6

1.6

—

Other and unspecified glaucoma

4.36

4.08

1.2

1.9

—

Weight loss

3.76

4.08

2.6

2.1

—

Glomerulonephritis

3.20

4.05

1.3

2.2

—

Genitourinary diseases

192

1.75

4.04

2.1

2.2

—

Acute pharyngitis

3.06

4.02

1.0

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

10.07

4.01

2.4

1.4

—

Multiple myeloma

10.07

4.01

2.4

1.4

—

Benign neoplasm: Small intestine

10.04

4.01

1.9

3.0

—

Other dialysis

6.47

3.99

1.0

2.4

—

Hepatic failure, not elsewhere classified

6.46

3.98

1.6

2.2

—

Pericarditis

6.46

3.98

2.8

1.9

—

Dialysis

6.46

3.98

1.1

2.3

—

Hyperkalaemia

6.45

3.98

2.7

1.4

—

Disorders of vitreous body and globe

267

1.83

3.97

1.9

2.0

—

5-aminosalicylic acid

3.02

3.95

1.9

1.3

—

Any operation in hilmo

+∞

3.93

1.4

0.0

—

Ptosis of eyelid

3.64

3.92

1.9

1.3

—

Urticaria and erythema

191

1.99

3.90

2.8

1.7

—

Nail disorders

3.43

3.90

3.8

2.0

—

Abnormal findings on diagnostic imaging of other body structures

3.43

3.90

1.1

1.7

—

Other and unspecified epidermal thickening

7.32

3.86

3.3

1.4

—

Blepharochalasis

119

2.27

3.86

2.2

1.7

—

Diverticular disease of intestine

273

1.68

3.85

2.3

2.1

—

Sequelae of external causes of morbidity and mortality

107

2.34

3.82

1.7

2.0

—

Other demyelinating diseases of the central nervous system

6.03

3.82

2.3

1.4

—

Other arrhythmias

272

1.72

3.80

2.1

1.9

—

Stomatitis and related lesions

3.80

1.7

1.4

—

Drug-induced osteoporosis with pathological fracture

8.85

3.78

3.1

1.4

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2.20

3.78

1.0

2.2

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2.20

3.78

1.0

2.2

—

Carcinoma in situ of skin of upper limb, including shoulder

8.82

3.78

1.6

1.4

—

Other melanin hyperpigmentation

8.82

3.78

3.4

1.4

—

Other superficial mycoses

8.82

3.78

4.9

1.8

—

Osteonecrosis due to drugs

12.15

3.77

1.7

1.4

—

Benign neoplasm: Duodenum

12.07

3.77

2.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.54

3.76

1.9

2.1

—

Other complications of surgical and medical care, not elsewhere classified

3.54

3.76

2.8

2.4

—

Viral and other specified intestinal infections

2.42

3.76

2.2

1.9

—

Phlebitis and thrombophlebitis (not including DVT)

102

2.36

3.73

1.9

—

Mood disorders, excluding more controls

375

1.54

3.72

2.2

2.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

6.69

3.67

2.4

1.0

—

Melanocytic naevi of lower limb, including hip

5.65

3.66

3.2

1.6

—

Other or unspecified ileus, impaction or obstruction

2.69

3.64

2.9

1.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

437

1.52

3.63

2.1

2.0

—

Paralytic ileus and intestinal obstruction

116

2.24

3.62

2.3

1.8

—

Peripheral artery operations in Hilmo

3.43

3.61

1.1

1.8

—

Type 2 diabetes, wide definition

344

1.57

3.60

2.1

2.0

—

Other and unspecified tonsillitis

148

2.01

3.60

1.6

1.8

—

Cerebral palsy and other paralytic syndromes

2.95

3.57

1.5

2.0

—

Conjunctivitis (acute, non atopic)

136

2.13

3.56

1.7

1.8

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.85

3.56

1.1

3.9

—

Other and unspecified injuries of shoulder and upper arm

7.82

3.56

4.1

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

293

1.61

3.56

2.2

2.0

—

Rheumatoid arthritis

179

1.93

3.56

1.2

2.0

—

Other arthritis (FG)

157

2.04

3.54

1.4

2.0

—

Intestinal stricture

137

2.12

3.53

2.4

2.0

—

conjunctival haemorrhage

3.86

3.52

1.9

—

Diseases of middle ear and mastoid

262

1.72

3.51

2.0

1.9

—

Hordeolum and other deep inflammation of eyelid

5.31

3.51

2.1

1.8

—

Noninfective enteritis and colitis

256

1.80

3.51

2.1

2.0

—

Hodgkin lymphoma

10.05

3.50

1.5

2.7

—

Superficial injury of head

2.33

3.49

1.2

1.9

—

Pain in joint

215

1.73

3.48

1.8

—

Ulcerative colitis, NAS

2.54

3.45

2.2

1.9

—

GI-bleeding

139

2.09

3.41

1.7

2.0

—

Other CVD

2.76

3.41

2.9

1.9

—

Follicular lymphoma, hilmo

5.02

3.37

1.1

2.2

—

Other and unspecified iridocyclitis

5.02

3.37

1.1

2.1

—

Urethral stricture

5.01

3.37

2.9

1.9

—

Low back pain

356

1.58

3.35

2.0

1.9

—

Volume depletion

3.71

3.35

2.0

1.7

—

Conduction disorders

104

2.16

3.35

1.6

1.8

—

Other congenital malformations

3.25

3.33

2.0

—

Other osteochondropathies

3.45

3.33

1.4

2.5

—

Amputation

3.44

3.33

1.1

2.1

—

Fall on same level

116

449

1.44

3.31

1.9

2.1

—

Diseases of the ear and mastoid process

118

414

1.44

3.29

2.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

155

2.00

3.28

2.3

1.8

—

Disorders of vitreous body

264

1.74

3.26

1.8

2.0

—

Dorsalgia

100

365

1.48

3.26

2.4

1.9

—

Episodal and paroxysmal disorders

108

378

1.46

3.26

2.4

1.9

—

Diabetes, varying definitions

100

405

1.48

3.24

2.3

1.9

—

Melanocytic naevi of other and unspecified parts of face

4.75

3.23

1.1

2.2

—

Diseases of tongue

4.75

3.23

1.4

1.3

—

Type 1 diabetes

122

2.13

3.23

1.4

1.9

—

Nasal polyp

2.38

3.22

2.7

1.7

—

Mood [affective] disorders

101

454

1.46

3.20

2.1

2.0

—

Hypertensive diseases

297

1.54

3.20

2.4

2.0

—

Oral leukoplakia and related diseases, including avohilmo

3.34

3.19

2.0

1.9

—

Papilloedema, unspecified

6.41

3.19

3.1

1.6

—

Other diseases of spinal cord

6.40

3.19

1.3

2.5

—

Other diseases of urinary system

100

382

1.47

3.18

2.0

2.1

—

Glaucoma

251

1.71

3.17

1.5

1.9

—

Dental caries 1 and operation codes

269

1.55

3.15

2.0

1.9

—

Other disorders of eye and adnexa

2.63

3.13

1.3

1.9

—

Other systemic involvement of connective tissue

111

2.16

3.11

1.9

1.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.51

3.11

3.3

2.0

—

Other diseases of the digestive system

138

2.03

3.09

1.6

1.9

—

Pain (limb, back, neck, head abdominally)

220

1.59

3.09

1.8

—

Other degenerative diseases of the nervous system

2.29

3.07

2.4

1.5

—

Gout

138

1.98

3.07

2.2

2.3

—

Psychiatric diseases

107

370

1.45

3.06

2.1

2.0

—

Respiratory tuberculosis, confirmed

7.55

3.06

1.3

1.4

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

7.55

3.06

1.3

1.4

—

Systemic sclerosis

7.54

3.06

3.3

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

251

1.74

3.06

1.7

2.0

—

Other and unspecified drugs and medicaments

3.24

3.05

1.8

2.1

—

Allergic urticaria

3.24

3.05

2.3

1.7

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

7.52

3.05

1.8

2.8

—

Other embolism and thrombosis

2.68

3.05

1.7

2.1

—

Varicella [chickenpox]

5.02

3.05

2.7

2.6

—

Depression medications

2.25

3.03

2.1

1.8

—

Filling of root of tooth

5.86

3.02

4.6

1.7

—

Erythema nodosum

5.86

3.02

2.4

1.8

—

Sleep apnoea

408

1.48

3.02

2.5

1.9

—

Hypertension

297

1.52

3.01

2.4

2.0

—

Lichen simplex chronicus and prurigo

4.30

2.99

1.8

1.9

—

Mood disorders

100

455

1.44

2.98

2.1

2.0

—

Dermatopolymyositis (FG)

10.08

2.98

3.8

1.4

—

Diabetic retinopathy, excluding more controls

2.04

2.98

1.8

2.7

—

Other diseases of anus and rectum

140

2.00

2.98

1.9

1.8

—

Benign neoplasm: Skin of eyelid, including canthus

3.00

2.97

1.0

2.2

—

Disorders of skin appendages

271

1.70

2.95

2.9

2.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

325

1.63

2.93

1.8

2.0

—

Optic neuritis

4.72

2.92

1.0

1.5

—

Cervicocranial syndrome

2.83

2.91

2.2

2.1

—

Hypotension

2.83

2.91

3.4

1.6

—

External causes of morbidity and mortality

220

1.57

2.90

1.9

2.1

—

L04AC Interleukin inhibitors

4.11

2.88

1.2

2.8

—

Chronic conjunctivitis

5.41

2.87

1.6

2.3

—

Benign neoplasm: Duodenum

6.70

2.87

2.0

1.4

—

Systemic sclerosis, icd10

6.70

2.87

3.3

1.8

—

Benign neoplasm: Small intestine

5.41

2.87

1.9

1.8

—

Melanocytic naevi of trunk

2.59

2.87

3.2

1.8

—

Endocarditis

6.69

2.87

1.0

2.3

—

Benign neoplasm: Choroid

6.68

2.87

1.2

2.6

—

Other symptoms and signs involving cognitive functions and awareness

207

1.77

2.86

1.7

1.8

—

Malignant neoplasm of skin

244

1.64

2.84

1.9

2.0

—

Disorders of thyroid, IBD co-morbidities

2.67

2.83

2.8

1.1

—

Sleep disorders (combined)

427

1.44

2.82

2.4

1.9

—

Septal defects

4.01

2.82

2.4

2.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

209

1.70

2.81

1.8

2.0

—

Delirium, not induced by alcohol and other psychoactive substances

3.06

2.80

1.5

2.2

—

Oesophageal varices

4.46

2.79

1.7

2.2

—

Ocular pain

3.23

2.77

1.2

1.6

—

Abnormal weight loss

3.23

2.77

2.9

1.7

—

Other systemic involvement of connective tissue (FG)

116

2.06

2.77

1.9

1.7

—

Special screening examination for other diseases and disorders

3.23

2.77

2.3

1.1

—

Spondylolisthesis/Spondylolysis

2.26

2.76

2.6

2.1

—

Inflammatory bowel disease

173

1.85

2.75

2.2

1.9

—

Brain glioblastoma and astrocytoma

8.39

2.75

1.4

1.3

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

8.38

2.75

1.0

3.0

—

Primary biliary cholangitis (PBC)

8.38

2.75

1.0

1.8

—

Viral conjunctivitis

8.38

2.75

1.2

1.5

—

Depression

441

1.44

2.73

2.2

2.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.02

2.73

2.0

2.4

—

Other disorders of bone

2.20

2.73

1.9

2.0

—

Diseases of liver

181

1.82

2.72

2.0

—

Carcinoma in situ of skin of trunk

6.03

2.70

1.5

1.6

—

Polycystic ovarian syndrome, consortium definition

225

1.58

2.68

2.0

1.7

—

Disorders of gallbladder, biliary tract and pancreas

419

1.43

2.67

2.3

2.0

—

Pure hypercholesterolaemia

268

1.55

2.66

2.2

2.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

138

1.94

2.65

1.4

1.9

—

Aortic aneurysm

2.22

2.65

2.2

2.1

—

Seborrhoeic dermatitis

2.80

2.64

2.9

2.0

—

Duodenal ulcer

3.13

2.64

1.3

1.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

147

1.91

2.64

1.9

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

409

1.43

2.62

1.9

2.1

—

Spondylopathies

311

1.48

2.62

2.0

—

Lower back pain or/and sciatica

466

1.41

2.61

2.2

2.0

—

Tumor necrosis factor alpha inhibitors

2.25

2.60

1.4

1.9

—

Ulcerative colitis

120

2.00

2.60

2.3

2.1

—

Herpesviral keratitis and keratoconjunctivitis

4.68

2.60

2.1

2.3

—

Recurring oral aphthae

4.68

2.60

1.4

1.7

—

Hard cardiovascular diseases

330

1.48

2.59

1.9

2.2

—

Irregular menses

190

1.71

2.58

1.9

1.7

—

Benign neoplasm: Transverse colon

2.90

2.58

3.3

1.9

—

Polyuria

100

2.10

2.58

2.4

1.9

—

Dental caries 2 and operation codes

393

1.48

2.57

1.8

2.0

—

Osteomyelitis

4.01

2.56

2.6

1.9

—

Visual impairment including blindness (binocular or monocular)

4.01

2.56

1.3

2.2

—

Other functional intestinal disorders

211

1.72

2.56

1.5

1.7

—

Dermatopolymyositis

7.20

2.55

3.8

1.4

—

Other and unspecified nail disorders

7.18

2.55

4.8

1.7

—

Chronic Coagulation defects

7.18

2.55

1.6

1.9

—

Benign neoplasm: Skin of trunk

7.16

2.55

3.0

—

Diabetes mellitus

411

1.41

2.55

2.1

2.0

—

Amputation of foot

5.48

2.54

1.0

2.3

—

Systemic sclerosis (FG)

5.48

2.54

3.3

1.4

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

5.46

2.54

1.8

2.3

—

Dental caries 2

396

1.47

2.54

1.8

2.0

—

Disorders of conjunctiva

423

1.47

2.53

2.0

—

Diabetic nephropathy

2.22

2.52

1.4

2.5

—

Benign neoplasm: Sigmoid colon

2.27

2.50

1.9

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2.30

2.49

2.1

2.3

—

Intestinal malabsorption

4.39

2.47

1.7

2.0

—

Other endocrine disorders

3.86

2.47

1.9

1.3

—

Need for other prophylactic measures

3.82

2.46

1.0

2.6

—

Tongue abnormality

3.82

2.46

1.5

2.0

—

Other diseases of stomach and duodenum

3.82

2.46

2.9

1.7

—

Other specified/unspecified arthritis

151

1.86

2.46

1.5

1.9

—

Congenital malformations of heart and great arteries

2.38

2.44

2.7

2.0

—

Other disorders of kidney and ureter

2.55

2.44

1.8

2.0

—

Parodontitis or/and operation codes

266

1.50

2.42

2.3

2.0

—

Coxibs

145

0.40

2.42

1.2

2.3

—

Disorders of refraction and accommodation

130

1.92

2.42

1.8

1.9

—

Myositis

5.02

2.40

1.2

1.6

—

Hodgkin lymphoma, hilmo

5.02

2.40

1.5

2.0

—

Other disorders of prostate

5.02

2.40

1.5

2.1

—

Benign neoplasm: Descending colon

5.01

2.40

2.0

2.3

—

Corns and callosities

3.34

2.39

1.1

1.9

—

Amenorrhoea

3.34

2.39

1.7

1.9

—

Combinations of oral blood glucose lowering drugs

176

0.34

2.39

1.3

2.3

—

Dental caries 3 and operation codes

292

1.44

2.38

2.0

1.9

—

Other specified/unspecified deforming dorsopathies

6.28

2.37

2.0

2.9

—

Background retinopathy and retinal vascular changes

6.28

2.37

1.6

1.5

—

Malignant neoplasm of other connective and soft tissue

6.28

2.37

1.0

1.5

—

Anaemia in chronic diseases classified elsewhere

6.28

2.37

1.2

1.6

—

Erythema multiforme

6.28

2.37

5.2

1.8

—

Prurigo nodularis

6.28

2.37

2.4

2.0

—

Suggestive for eosinophilic asthma

2.76

2.37

1.8

1.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

150

1.76

2.37

1.6

1.9

—

Distal bite

6.22

2.36

2.6

1.3

—

Juvenile arthritis (FINNGEN)

4.13

2.36

1.0

1.8

—

Other aneurysm

4.13

2.36

3.1

1.9

—

Benign neoplasm: Colon, unspecified

2.20

2.34

2.5

2.3

—

Other (seronegative) rheumatoid arthritis, wide

2.15

2.34

1.3

2.1

—

Peripheral artery disease

170

1.71

2.33

1.6

2.0

—

Hypertension, essential

290

1.46

2.33

2.1

2.0

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

2.73

2.31

2.6

2.2

—

Migraine

233

1.61

2.31

1.9

1.8

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

3.22

2.30

1.3

2.2

—

Any mental disorder

104

380

1.37

2.29

2.3

1.9

—

Diabetic nephropathy, excluding more controls

2.15

2.28

1.4

2.8

—

Diseases of peritoneum

2.69

2.27

1.5

2.1

—

Cardiomyopathies, Primary/intrinsic

2.69

2.27

1.5

1.9

—

Manic episode

4.63

2.27

2.8

2.2

—

Simple and mucopurulent chronic bronchitis

4.63

2.27

2.3

1.6

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

4.62

2.27

1.8

2.1

—

Basal cell carcinoma

225

1.59

2.27

2.1

2.0

—

Ingrowing nail

3.49

2.27

3.8

2.5

—

Acute peritonitis

3.49

2.27

1.5

2.1

—

Hydrocephalus

3.48

2.27

1.1

1.9

—

Myocardial infarction, unclassifiable

2.31

2.26

1.7

1.8

—

Disturbances of skin sensation

134

1.87

2.25

2.4

1.9

—

Oesophagitis

3.90

2.25

1.6

1.7

—

Benign neoplasm of middle ear and respiratory system

3.89

2.25

3.9

2.3

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.28

2.24

2.0

2.2

—

TMD related operations

2.10

2.22

2.8

2.0

—

Exclusions for E4_PCOS_BROAD

2.09

2.22

1.7

1.8

—

5.58

2.21

1.2

2.7

—

Hypoplasia of dental enamel , including avohilmo

5.51

2.19

2.4

1.2

—

Superficial injury of hip and thigh

2.41

2.19

1.5

2.1

—

Congenital malformations, deformations and chromosomal abnormalities

344

1.50

2.19

2.4

2.0

—

Other shoulder lesions

2.50

2.18

2.7

2.0

—

Hypothyroidism, drug reimbursement

2.60

2.18

2.1

2.0

—

Other disorders of ear

407

1.39

2.18

2.1

2.0

—

Molar incisor enamel hypoplasia

5.46

2.18

2.4

1.2

—

Unspecified haematuria

192

1.65

2.18

2.3

2.1

—

Vulvovaginal ulceration/inflammation in other diseases

3.34

2.18

2.5

1.8

—

Amputation of toe

3.34

2.18

1.1

2.0

—

Other diseases of jaws

3.34

2.18

2.9

1.3

—

Deviated nasal septum

195

1.69

2.17

2.1

2.2

—

Retinal breaks without detachment

2.24

2.17

1.2

2.1

—

Gout, unspecified

2.07

2.16

2.6

2.2

—

Tinnitus

122

1.89

2.15

1.7

2.0

—

Sub-endpoint used in defining T1D endpoints

134

1.84

2.15

1.4

1.9

—

Other specified and unspecified disorders of eye and adnexa

4.30

2.15

1.3

2.4

—

Respiratory tuberculosis, not confirmed

4.30

2.15

3.0

1.7

—

Subjective visual disturbances

101

1.98

2.15

1.9

2.0

—

Stroke, excluding SAH

260

1.52

2.14

1.7

2.1

—

Nerve, nerve root and plexus disorders

444

1.36

2.12

1.8

2.1

—

Bell's palsy

2.37

2.12

1.7

2.1

—

Other retinal disorders

270

1.52

2.11

1.5

2.1

—

Amiodarone users

2.71

2.10

2.0

1.9

—

Other and unspecified visual disturbances

2.71

2.10

1.3

2.2

—

Other/unspecified reactive arthropathies

3.21

2.09

2.9

1.7

—

Chronic ulcer of skin, not elsewhere classified

3.21

2.09

1.9

2.0

—

Benign neoplasm of eye and adnexa

3.20

2.09

1.3

1.9

—

Symptoms and signs involving the nervous and musculoskeletal systems

331

1.51

2.09

1.8

1.9

—

Other and unspecified disorders of vitreous body

212

1.64

2.08

1.8

2.0

—

Unspecified nephritic syndrome

5.02

2.07

1.0

1.3

—

Other dorsopathies, not elsewhere classified

368

1.36

2.07

2.2

2.0

—

Fibrosis and cirrhosis of liver

2.91

2.07

2.1

1.7

—

Benign neoplasm of urinary organs

5.01

2.07

1.0

2.4

—

Sequelae of infectious and parasitic diseases

2.91

2.07

1.4

2.5

—

Degenerative macular diseases

2.91

2.07

2.1

1.7

—

Appendectomy

429

0.58

2.06

2.2

2.0

—

Lesion of lateral popliteal nerve

3.51

2.05

3.4

2.3

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2.32

2.04

2.2

2.3

—

Sixth [abducent] nerve palsy

4.02

2.04

1.8

2.0

—

Somnolence, stupor and coma

4.01

2.04

1.5

2.3

—

Atrial septal defect

3.98

2.02

2.2

2.3

—

Other diseases of arteries and capillaries

3.08

2.01

2.0

1.7

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

3.08

2.01

2.3

—

Inguinal hernia, bilateral

2.50

2.01

1.9

2.1

—

Inguinal or femoral hernia, bilateral

2.50

2.01

1.9

2.1

—

Diabetic retinopathy

114

1.72

2.01

1.8

2.3

—

Pruritus

2.64

2.01

2.8

1.3

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

2.25

1.98

2.4

2.2

—

Leiomyoma of uterus

1.76

1.98

1.7

2.2

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1.98

1.97

1.1

2.2

—

Unknown and unspecified causes of morbidity

3.34

1.96

1.7

1.9

—

Cystitis

298

1.42

1.95

1.7

2.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

225

1.60

1.95

1.9

—

Gout, idiopatic and unspecified

105

1.91

1.95

2.4

2.2

—

IgA nephropathy (IgA glomerulonephritis)

4.56

1.94

1.2

2.3

—

Other specified and unspecified retinal disorders

4.56

1.94

2.2

1.9

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

4.55

1.94

1.2

2.3

—

Basal cell carcinoma, including avohilmo

232

1.53

1.94

2.1

2.0

—

Vascular syndromes of brain in cerebrovascular disorders

3.76

1.93

1.2

2.2

—

Other juvenile arthritis

3.76

1.93

1.0

1.9

—

Cardiomyopathy, other and unspecified

2.97

1.93

1.3

2.1

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.73

1.93

1.2

2.1

—

Impacted cerumen

2.73

1.93

1.2

1.7

—

Embedded teeth, including avohilmo

2.73

1.93

2.4

2.2

—

Follow-up examination after treatment for malignant neoplasms

2.73

1.93

1.1

—

Aortic valve malfunction, age under 60 years

2.45

1.93

2.6

2.3

—

Complications of procedures, not elsewhere classified

405

1.41

1.92

1.6

2.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.57

1.92

1.2

2.1

—

Symptoms and signs involving speech and voice

157

1.72

1.92

1.5

2.0

—

Irritable bowel syndrome

135

1.78

1.90

1.7

—

Sequelae with surgical and medical care as external cause

2.00

1.89

1.6

1.9

—

Other noninfective gastroenteritis and colitis

106

1.89

2.3

1.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

234

0.49

1.89

1.9

1.8

—

Angina pectoris

243

1.47

1.89

2.4

2.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

187

1.65

1.88

1.6

1.9

—

Abnormalities of forces of labour

0.00

1.88

0.0

1.7

—

Oral leukoplakia and related diseases

3.19

1.88

2.0

1.9

—

Hypothyroidism and >3 levothyroxin purchases

1.99

1.87

1.2

1.8

—

Hypothyroidism, levothyroxine purchases

1.99

1.87

1.2

1.8

—

Stroke, including SAH

280

1.45

1.87

1.7

2.1

—

Hypothyroidism (congenital or acquired)

1.99

1.86

1.3

1.8

—

Infectious mononucleosis

2.65

1.86

1.0

2.6

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.86

1.86

1.1

1.8

—

Benign neoplasm of mouth and pharynx

2.86

1.86

1.5

2.2

—

Exposure to unspecified factor

491

1.34

1.85

1.7

2.1

—

Cardiomyopathy (excluding other)

2.39

1.85

1.5

2.2

—

Speech and linguistic disorders, excluding more controls

3.14

1.84

2.3

1.5

—

Open wound of ankle and foot

2.21

1.84

1.1

2.1

—

Ischaemic Stroke, excluding all haemorrhages

244

1.49

1.83

1.6

2.1

—

Muscle strain

4.18

1.82

2.8

1.6

—

Other and unspecified follicular disorders

4.18

1.82

1.4

2.2

—

Cysts of oral region, not elsewhere classified

4.18

1.82

2.2

1.5

—

Family history of certain disabilities and chronic diseases leading to disablement

4.17

1.82

1.0

—

Other/unspecified dorsalgia

213

1.59

1.81

2.3

1.9

—

Thoracic aortic aneurysm

2.27

1.80

2.7

2.1

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

2.19

1.80

1.0

2.3

—

Erectile dysfunction

2.58

1.80

1.0

2.0

—

Hypopituitarism

2.58

1.80

2.3

—

Spinal stenosis

229

1.51

1.80

2.3

2.0

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

3.05

1.80

1.3

2.4

—

Reactive arthropathies, FINNGEN

2.76

1.79

2.9

2.4

—

Benign neoplasm of breast

2.76

1.79

1.3

2.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.34

1.77

2.6

2.3

—

Poor fetal growth

2.34

1.77

2.0

1.6

—

Atrial fibrillation and flutter with reimbursement

1.80

1.76

2.7

2.0

—

Acetic acid derivatives and related substances

144

0.51

1.75

1.1

2.2

—

Perforation of tympanic membrane

2.44

1.75

2.0

2.1

—

Abnormal findings on examination of urine, without diagnosis

3.34

1.74

2.8

1.6

—

Injury of muscle and tendon at lower leg level

2.03

1.74

1.7

2.2

—

Chondropathies

1.98

1.74

2.1

1.9

—

Pleural plaque

2.67

1.72

2.9

1.6

—

Acute lymphadenitis

2.92

1.72

1.6

2.4

—

Nephrotic syndrome

3.86

1.71

1.0

1.5

—

Hypoparathyroidism

3.86

1.71

2.4

1.6

—

Adrenocortical insufficiency

3.86

1.71

1.2

1.5

—

Myocarditis

3.85

1.71

1.0

2.2

—

Recurrent or chronic depression

196

1.51

1.69

2.8

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

262

1.41

1.69

1.8

1.9

—

Injury, poisoning and certain other consequences of external causes

187

1.45

1.69

1.7

2.2

—

Fracture of lumbar spine and pelvis

2.00

1.68

1.1

1.7

—

Sleep apnoea, including avohilmo

422

1.32

1.67

2.5

2.0

—

Vasomotor and allergic rhinitis

200

1.58

1.67

2.6

1.8

—

Primary gonarthrosis, bilateral

268

0.55

1.66

1.4

2.0

—

Hyperfunction of pituitary gland

3.16

1.66

1.5

1.8

—

Persons encountering health services in circumstances related to reproduction

257

1.42

1.66

2.1

2.0

—

Pyogenic arthritis

2.58

1.66

1.1

2.3

—

Glaucoma, exfoliation

2.80

1.65

1.1

1.5

—

Acute nasopharyngitis (common cold)

2.17

1.65

1.8

2.0

—

Dental pulpitis 2

214

1.41

1.64

1.9

—

Inguinal hernia

245

1.43

1.64

2.4

2.2

—

Superficial injury of abdomen, lower back and pelvis

1.98

1.64

1.3

1.9

—

Heart failure and bmi 25plus

112

1.66

1.63

2.4

2.0

—

Sequelae of cerebrovascular disease

131

1.68

1.62

1.8

2.0

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.58

1.61

1.0

1.6

—

Temporal arteritis

3.58

1.61

1.2

1.6

—

Arthropathies in other diseases classified elsewhere

3.58

1.61

2.0

—

Giant cell arteritis

3.58

1.61

1.2

1.6

—

Complications of other internal prosthetic devices, implants and grafts

3.58

1.61

2.2

1.6

—

Other congenital malformations of skin

3.58

1.61

2.4

1.6

—

Other/unspecified rheumatoid arthritis

2.33

1.60

1.3

1.7

—

Corneal ulcer

1.87

1.60

1.5

1.9

—

Nummular dermatitis

2.50

1.59

3.1

1.9

—

Collagenous colitis

2.50

1.59

2.8

1.6

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

2.50

1.59

3.5

2.2

—

Disorders of speech understanding and production

3.51

1.58

1.2

1.5

—

Tobacco use

3.01

1.58

1.2

2.3

—

Neuralgia and neuritis, unspecified

3.01

1.58

2.0

1.8

—

Benign neoplasm: Choroid

3.01

1.58

1.2

2.0

—

Other noninflammatory disorders of vagina

2.70

1.58

1.0

1.9

—

Benign neoplasm: Caecum

2.70

1.58

2.1

1.9

—

Diabetes medication

420

1.30

1.57

2.2

1.9

—

Conjunctivitis

388

1.37

1.57

2.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.00

1.57

2.2

2.0

—

Other anxiety disorders

211

1.51

1.56

2.8

1.9

—

Type 2 diabetes

395

1.31

1.56

2.0

—

Calcific aortic valvular stenosis, operated

104

1.79

1.56

1.4

1.9

—

Calcific aortic valvular stenosis

104

1.79

1.56

1.4

1.9

—

Calcific aortic valvular stenosis, diagnosis (helper)

104

1.79

1.56

1.4

1.9

—

Operations 2 for CAVS

104

1.79

1.56

1.4

1.9

—

Other external causes of accidental injury

297

1.33

1.56

1.9

2.2

—

Acute laryngitis and tracheitis

2.46

1.56

1.8

1.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.89

1.55

2.6

1.9

—

Glucagon-like peptide-1 (GLP-1) analogues

277

1.43

1.55

2.2

2.0

—

Other problems related to primary support group, including family circumstances

2.19

1.54

1.0

2.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.92

1.54

1.3

2.0

—

Colectomy operation

2.03

1.54

2.4

2.0

—

Correction of physiology of bite - demanding therapy visit

2.43

1.53

3.0

1.6

—

Injury of unspecified body region

2.43

1.53

2.4

2.1

—

Disorders of parathyroid gland

1.92

1.53

1.7

1.9

—

Retinal detachment with retinal break

2.28

1.53

2.2

2.0

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2.27

1.53

2.6

2.3

—

Recurrent dislocation and subluxation of joint

0.00

1.52

0.0

2.0

—

Giant cell arteritis with polymyalgia rheumatica

3.34

1.52

1.2

1.8

—

Chronic hepatitis, not elsewhere classified

3.34

1.52

1.4

2.1

—

Chronic nephritic syndrome

3.34

1.52

1.8

2.3

—

Impetigo

3.34

1.52

1.6

3.0

—

Calcific aortic valvular stenosis, including rheumatic fever

105

1.77

1.52

1.4

1.9

—

Scleritis and episcleritis

2.60

1.51

1.0

2.6

—

Other and unspecified psoriasis

2.60

1.51

2.9

2.3

—

2.17

1.50

1.4

1.6

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

144

0.42

1.50

3.5

2.1

—

Benign neoplasm: Cerebral meninges

2.86

1.50

2.7

1.8

—

Entropion and trichiasis of eyelid

2.86

1.50

2.2

1.4

—

1.84

1.50

1.8

1.5

—

Soft tissue disorders related to use, overuse and pressure

146

1.65

1.50

2.5

2.0

—

Injuries to the hip and thigh

213

1.50

1.9

—

Cardiac arrest

3.32

1.49

2.4

1.3

—

Crohn disease

1.95

1.48

2.2

2.0

—

Type 1 diabetes, wide definition

101

1.78

1.48

1.4

1.7

—

Dislocation, sprain and strain of joints and ligaments of knee

399

0.65

1.48

1.4

2.1

—

Excessive attrition of teeth

107

1.57

1.47

2.5

1.7

—

Mixed conductive and sensorineural hearing loss

2.22

1.46

1.5

1.6

—

Diseases of male genital organs

191

1.40

1.45

2.3

2.4

—

Intracerebral haemorrhage

2.37

1.45

1.9

1.8

—

Presbyopia

2.50

1.45

1.7

2.4

—

Mental and behavioural disorders due to opioids

3.13

1.44

2.6

3.1

—

Total colectomy operation

3.13

1.44

3.4

2.2

—

Total colectomy

3.13

1.44

3.4

2.2

—

All dysplastic lesions of the vulva

3.13

1.44

2.0

1.6

—

Other disorders of adrenal gland

3.13

1.44

1.2

2.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS